Weekly Commentary: 23/11/20 – Expectations rising

We are beginning to see companies operating in the “real” economy announce raised guidance. Somero (exceeding previous revenue guidance by +7%), but also Headlam (materially ahead), Acesso (comfortably ahead). Saga share price was also up +57% during the week. The FTSE 100 is currently 6378, which is the same level as early March this year. […]

Screening For My Next Long-Term Winner: Manolete Partners

I am always looking for ‘multi-baggers’ — investments that can double, triple, quadruple or more. And here’s some very good news: I have stumbled on a company that can find them for me. Not just the occasional five-bagger or ten-bagger mind, but 20-baggers. It’s incredible stuff, especially as the track record of success extends for […]

Alpesh Patel on US Investing: The Stocks that “Have It All”

Like humans, such perfection doesn’t exist in stocks. Like humans, fish in a big enough pond, and for a while, some get as close as possible. Are they the brands people love the most? Some research by MBLM suggests so. See these images: Wow, great performing companies, and they outgrow their peers. Plus, they are […]

The Trader: A look at the commodities sector

The commodities sector is popular with private investors and retail traders. Life changing gains (and life changing losses) can be made on this sector. Back the right minor and you can see stocks appreciate in value several-fold, although the vast majority never amount to anything other than value destruction through endless placings. In this article […]

Weekly Commentary: 09/11/20 – Study silence to learn the music

The US Presidential election turned out to be closer than most people expected. Nasdaq up almost +10% over the week to 12078. Tech stocks reacted well to the uncertainty, but so did 10 year US Bond yields, which initially jumped to 0.9% before falling back to 0.78%. I’m not sure if you’d predicted the result, […]

Alpesh Patel on US Investing: 3 “Strong Buy” looking stocks set to move up

There is no shortage of stocks that are delivering triple digit returns. Scholar Rock, Miragen, Zedge, Socket Mobile – even Tupperware is up nearly 1,000%. Source: ShareScope – Alpesh Patel Special Edition (click on image to enlarge) The problem is hindsight is great, but each of these and the other climbers have huge problems in […]

Screening For My Next Long-Term Winner: Jarvis Securities

Today I have returned to one of my favourite SharePad screens. This screen applies two ratios favoured by ‘quality’ investors — operating margin and return on equity (ROE). The main filter criteria are: 1) An operating margin (latest and 10-year average) of 20% or more, and; 2) An ROE (latest and 10-year average) of 20% […]

Weekly Commentary: 02/11/20 – Insiders selling at the top?

Last week markets sold off into the rising cases of Covid. The FTSE 100 fell 5% last week to 5561. Large UK banks HSBC and NatWest reported encouraging results, although the sector remained unloved. Directors selling Given the strength of the market’s rally over the last 6 months, and then last week’s sell off, I […]

Floored

James Halstead makes vinyl flooring, the kind we see in hospital corridors, GP surgeries, clinics, schools, offices, laboratories, prisons, factories, shops, trains and boats around the world. James Halstead’s biggest brand is Polyflor. The company’s social media accounts are a good way to get a feel for the product and you can take the Commercial […]

Weekly Commentary: 19/10/20 – On network effects and fads

“Fad companies are companies with good business models or good products. So, why would we be interested in shorting a company that has a good product? Because of the threat it presents to others and their likely response to that threat. For example, Netflix had a terrific idea of renting DVDs through the mail, which […]

Weekly Commentary: 12/10/20 – On content, distribution and kurtosis

Last week the FTSE recovered to just over 6000. The (perhaps inappropriately named) Bond film No Time to Die, was postponed until next year by its Hollywood studio, MGM, which has left cinemas in trouble. Cineworld is on the brink, a victim of an overly leveraged balance sheet but no product to distribute. Up until […]

Weekly Commentary: 05/10/20 – On uncertainty and confidence

Last week Andy Haldane at the Bank of England gave an interesting speech on “Economic Anxiety” noting that pessimism can be as contagious as the disease. Haldane is most famous for his “Dog and the Frisbee” speech, which he co-wrote with the famous psychologist Gerd Gigarenzer in 2012. Catching a frisbee is difficult; theoretically it […]

What does not kill a business can make it stronger

This article was not supposed to be about paper maker James Cropper. I set out to write about Animalcare, a veterinary pharmaceutical company, but I quickly became disillusioned, wretched even. You probably will hear about Animalcare one day, because it is an interesting business, but it is also complicated and its complicatedness was epitomised by […]

Weekly Commentary: 28/09/20 – Beginner’s mind and Buy and Build

Markets sold off last week as virus case rises rose (FTSE 100 fell to below 5800 before recovering slightly later in the week, Nasdaq down 4% to 10,800). The virus itself seems reasonably predictable, everyone has been expecting cases to rise as summer turns to autumn. What hasn’t been predictable is Government responses around the […]

Weekly Commentary: 21/09/20 – The long journey to exoneration

The FTSE 100 just about held its level above 6000 last week. Last week was Chilean Independence Day. It is a little known footnote in history that Lord Cochrane, who was involved in the great Stock Exchange scam of 1814 (accused of starting rumours of Napoleon’s death via the Admiralty’s semaphore telegraph) helped not one, […]

This time is different for Design Group

If you watch Design Group’s annual results presentation, you may detect a bashful smile on chief executive Paul Fineman’s face. Paul Fineman, chief executive of Design Group. Source: Design Group Full Year Results 2020 (video). Despite unexpected tariffs on products imported into the USA from China and the onset of the pandemic, Design Group was […]

Screening For My Next Long-Term Winner: Fuller, Smith & Turner

First, a wealth warning. The last price-to-book ‘bargain’ I looked at for SharePad was Hammerson. Back then the property group’s £5 billion asset base could be acquired for a £1.6 billion market cap. Investors were in theory able to purchase £1 of assets for just 30p. Twelve months on, and the share price below tells […]

A safety first stock

I found James Latham a couple of months ago when I was trawling for cheap shares with strong balance sheets. The shares are still cheap, James Latham’s Price Earnings (PE) ratio is 13, and the balance sheet should remain strong… Centuries trading timber James Latham has a long and storied history. It manufactured plywood for […]

Preparing for the worst, capitalising on the best

Listening to Porvair’s long-standing chief executive Ben Stocks talk about the challenges ahead, it is clear the company is bracing itself. Phrases like “preparing for the worst, hoping for the best”, and “the overall balance is negative”, come readily to him. This is a company I have long admired, but I have never had the […]

Prudent 15: Ecofin Global Utilities and Infrastructure Trust (EGL)

I do not think it is unfair to say that over the last decade we have seen a powerful shift in sentiment towards utility stocks, arguably in a very negative direction. For much of the last few decades, private investors could not get enough of these boring stocks. They paid out a generous dividend, seem […]

Screening For My Next Long-Term Winner: Fever-Tree Drinks

They say mums always know best. Mine has bought Fever-Tree tonic waters for some years now and I recently asked whether she remained a customer. This was her response. “While we don’t buy many commercial drinks for home consumption these days I would still definitely buy Fever-Tree, generally the original tonic water. I went into […]

Making a new discoverIE

I discovered discoverIE using a simple and fruitful method of finding new investment ideas: a list of shares sorted in SharePad by previous annual report date. Having squinted for a few minutes at financial charts showing profitability, cashflow and debt (more on that later), I thought the company looked promising: Sorting a list in SharePad […]

A cheap profitable share with a strong balance sheet

Today I have added two more criteria to turn the list of cheap shares with strong balance sheets I made in my last article into a list of cheap profitable shares with strong balance sheets! The profitability criteria are free cash conversion and return on capital employed. This table shows the individual and aggregated rankings […]

Screening For My Next Long-Term Winner: Frontier Developments

Has the market become too obsessed with ‘pandemic-proof’ shares? I ask because my SharePad screening has brought Frontier Developments to my attention. The shares of this computer-game developer have leapt 66% so far this year as industry sales rally during the lockdown. However, Frontier’s accounting looks rather questionable and the near-£800 million market cap seems […]

Dynamic 35: Hg Capital

A smarter way of buying into the right kind of private growth businesses It is an unfortunate truth that more and more high growth businesses are choosing to stay private and ignore the public markets. Collectively we investors, institutional and private have done our best to make life difficult for highly rated , fast growing […]

Screening For My Next Long-Term Winner: Hikma Pharmaceuticals

One way to invest during the pandemic is to consider shares that have climbed higher as the market has dropped. Such companies may well be ‘safe havens’ — businesses that are coping well with the lockdown, or perhaps even benefitting from the crisis. I applied the following simple criteria within SharePad to identify potential ‘pandemic-proof’ […]

Screening For My Next Long-Term Winner: A Covid-19 Special

Let me start with a confession.This Covid-19 ‘Special’ may not be all that special. I have just applied a new SharePad screen to seek ‘quality bargains’ amid the market chaos — and sadly the results were not that inspiring. The problem is nothing to do with me or my filters or SharePad. Instead, the Covid-19 […]

Putting safety first

Funny thing (peculiar, not ha! ha!). Search SharePad news for the phrase “strong balance sheet” and there are dozens of companies every day confirming their finances are strong as they reflect on the prospect of reduced, or in some cases, no revenue for a while. Search SharePad news for the phrase “weak balance sheet” though […]

Prudent 15: BH Global

Kicking off with BH Global (BHGG) You can always read more about my views on funds at my blog www.adventurousinvestor.com. I update this most days, especially useful during these volatile times when new investment opportunities emerge very quickly. I’m not going to bore readers with speculation about viruses and volatility but simply ask them to […]

Weekly Commentary: 16/03/20 – Timing is everything

Timing is everything With the current crisis Jeremy dusts off the recovery stocks folder. Airlines that survive will have huge upside on the back of a lower oil price. The opportunity may be in the likely refinancing issues, and Primary bid is a useful tool to enables retail investors to participate. Jeremy registers his interest […]

Screening For My Next Long-Term Winner: AB Dynamics

Recent market ructions have sent many shares tumbling — and perhaps created some buying opportunities. Amid the mayhem, I devised a straightforward screen. I simply looked for decent-sized businesses that were still expected to grow, paid a dividend and were conservatively financed, too I applied the following criteria within SharePad to identify some respectable candidates: […]

Going for repeat business

Fundsmith Equity probably needs no introduction. Since its launch in November 2010 the fund has racked up class-leading annualised returns of more than 18%, compared to less than 12% for an index of global equities, by investing in high quality businesses at attractive valuations. You can, of course, make further comparisons, and explore the makeup […]

Dynamic 35: Syncona

The genomics revolution and the appeal of Syncona It’s easy to get carried away with the short to medium term noise coming out of stock markets. The corona virus has sent investors in the developed world heading for the exit. But in truth some sectors of the giant ‘technology’ sector were already beginning to suffer […]

Next Page » « Previous Page